In Dec. 2020, the National Heart, Lung and Blood Institute (NHLBI) updated the clinical asthma guidelines . You may be wondering how that affects your child’s asthma treatment plan. One change from the guidelines is a treatment method called single maintenance and reliever therapy , or simply SMART . With SMART, an inhaler that contains two medicines – a inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA) – can be used for both asthma quick-relief and control. Studies show…
Lesen Sie weiter auf: Think SMART: What Is the Right Asthma Medicine Plan For Your Child?
Quelle: Asthma and Allergy Foundation of America
Titelbild/Grafik by Asthma and Allergy Foundation of America (AAFA)
Kommentare und Fragen
Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!Weiteres von Asthma and Allergy Foundation of America
- UnitedHealthcare to Get Rid of Out-of-Pocket Costs for Albuterol and Epinephrine
- Managing and Treating Severe Asthma (Webinar)
- Managing Moderate-to-Severe Atopic Dermatitis (Webinar)
- Coronavirus (COVID-19): What People With Asthma Need to Know
- The COVID-19 Vaccine: the Latest Information for People With Asthma and Allergies
- What People With Asthma Need to Know About Face Masks During the COVID-19 Pandemic
- If You Have Asthma, Protect Yourself From Summer Heat and Smog
- Climate Change: the Effect on People With Allergies and Asthma
- FDA Authorizes Pharmacists to Prescribe Paxlovid for COVID-19 With Limitations
- Tell Congress to Act on Health Equity Now
-
Produkthinweis*
UTAG Notfall-USB-Stick im Kreditkartenformat (344)
* = Affiliate Links / Bilder von der Amazon Product Advertising API / Aktualisiert am: 14.08.2022
